COVID
1 competing product in clinical development for COVID.
Pipeline by Phase
Phase 2/31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| mavrilimumab | Kiniksa Pharmaceuticals | Phase 2/3 | Completed | 60 |
1 competing product in clinical development for COVID.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| mavrilimumab | Kiniksa Pharmaceuticals | Phase 2/3 | Completed | 60 |